NANABIS-S
Dead / Abandoned — Abandoned — failure to respond (as of 18 Oct 2023)
What this means for you
This application is over — abandoned 06 Oct 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 79339592
- Mark type
- Stylized text
- Filed
- 28 Feb 2022
- Abandoned
- 06 Oct 2023
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and medicinal preparations and substances including pharmaceutical and medicinal preparations incorporating sub-micron particles; dietetic substances adapted for medical use; vitamins and vitamin supplements; dietary and nutritional products for medical purposes; dietary and nutritional supplements; minerals and mineral supplements; nutritional supplements; plant extracts for medical use; medicinal herbs for pharmaceutical and medicinal preparations and substances; herbal preparations for medicinal purposes; medicinal herbs for pharmaceutical and medicinal preparations and substances incorporating sub-micron particles; herbal preparations for medicinal purposes incorporating sub-micron particles
Owner
- Medlab IP Pty Ltd, NS, CA
Prosecution history
- 09 Nov 2024 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 21 Oct 2024 — FINAL DISPOSITION NOTICE SENT TO IB
- 19 Oct 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 31 Oct 2023 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 18 Oct 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 18 Oct 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 18 Oct 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 11 Oct 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 11 Oct 2023 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 25 Apr 2023 — REFUSAL PROCESSED BY IB
- 05 Apr 2023 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 05 Apr 2023 — REFUSAL PROCESSED BY MPU
- 17 Feb 2023 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 16 Feb 2023 — NON-FINAL ACTION WRITTEN
- 13 Feb 2023 — ASSIGNED TO EXAMINER